Stocks · News reference

Embecta Q3 Adj. EPS $0.56 Beats $0.27 Estimate, Sales $271.700M Beat $254.525M Estimate

Aug 7, 2026, 10:35 AMBenzinga Newsdesk

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

Globenewswire IncAug 31, 2026, 9:00 PMNa
embecta to Participate in Investor Events
Embecta Corp. (EMBC) announced that management will participate in investor events at the Wells Fargo 2026 Healthcare Conference on September 9, 2026, in Boston and the J.P. Morgan 4th Annual Nashville Healthcare Conference 2026 on September 10, 2026, where they will host fireside chats and one-on-one investor meetings.
EMBC
BenzingaAug 7, 2026, 5:05 PMBenzinga Insights
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers AVITA Medical (NASDAQ:RCEL) stock rose 58.4% to $7.53 during Friday's regular session. The company's market cap stands at $146.1 million. As per the press release, Q2 earnings came out yesterday.
AMIX BIVI CVRX DOCS EMBC
BenzingaAug 7, 2026, 12:59 PMBenzinga Newsdesk
Embecta shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY26 adjusted EPS guidance above estimates.
EMBC
Globenewswire IncAug 7, 2026, 10:30 AMUnknown
Embecta Corp. Reports Third Quarter Fiscal 2026 Financial Results
Embecta Corp. (NASDAQ: EMBC), a global medical supplies company with a 100-year legacy in insulin delivery, announced its third quarter fiscal 2026 financial results on August 7, 2026. The company hosted a conference call and webcast for analysts and investors to discuss the earnings.
EMBC